Author

Kim Chan

Northeastern University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Assay:flow cytometry· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Diomedes E. LogothetisiD· 2 shared Evangelos DadiotisiD· 2 shared Ana Santa‐CruziD· 1 shared Andrew Zorn· 1 shared Ganesh A. ThakuriD· 1 shared Georgios SkiniotisiD· 1 shared Jahnavi SimhadriiD· 1 shared Kyriaki SidiropoulouiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Diomedes E. LogothetisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GAT1508, a selective neuronal GIRK1/2 activator, exhibits superior antiepileptic efficacy and synergizes with cannabidiol

Jahnavi Simhadri, Andrew Zorn, Liang Wang, Takeharu Kawano, Natalia Cordero Ruiz, Lida Evmorfia Vagiaki, Nousheen Parvaiz, Mehreen Parvaiz, Lucas Cantwell, Kim Chan, Ana Santa‐Cruz, Evangelos Dadiotis, Nicole Rivera, Wilder Felix, Ganesh A. Thakur, , Stelios M. Smirnakis

This study characterizes GAT1508, a selective neuronal GIRK1/2 activator, showing superior antiepileptic efficacy and synergy with CBD.

bioRxiv · Oct 16, 2026 · PreprintPharmacology & Toxicology

Ion Channel Nano-Diagnostics for ER+ Breast Cancer

Manos Gkikas, Evangelos Dadiotis, Mehreen Zaka, Nihal Aly, Kim Chan, Diomedes E. Logothetis

This paper develops GAT1508-coated gold nanoparticles for detecting ER+ breast cancer cells through specific binding to GIRK1 channels, validated by flow cytometry and electrophysiology.

Journal of Biological Chemistry · Oct 1, 2026Peer-reviewedBioengineering